Dow Jones
37 903,29 +87,37 (+0,23 %) Nasdaq
15 605,48 -52,34 (-0,33 %) Nikkei 225
38 301,96 +27,91 (+0,07 %) EUR/USD
1,0718 0,0000 (-0,00 %) HANG SENG
18 102,31 +339,28 (+1,91 %) Bitcoin EUR
53 636,81 -2 470,49 (-4,40 %)
Sartorius Aktiengesellschaft (SARTF)
Sartorius Aktiengesellschaft
Otto-Brenner-Strasse 20
Göttingen 37079
Germany
49 551 308 0
https://www.sartorius.com
Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 14 614
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Dr. Joachim Kreuzburg | Chairman of Executive Board & CEO | 1,15M | S.O. | 1965 |
| Dr. Rene Faber | Head of Bioprocess Solutions Division & Member of Executive Board | 653,84k | S.O. | 1975 |
| Dr. Alexandra Gatzemeyer | Head of the Lab Products & Services Division and Member of Executive Board | 572,77k | S.O. | S.O. |
| Ms. Petra Kirchhoff | Head of Corporate Communications & Investor Relations and Member of Supervisory Board | 87,46k | S.O. | 1969 |
| Dr. Florian Funck Dipl.Kfm. | CFO & Member of Executive Board | S.O. | S.O. | 1971 |
| Ms. Patricia Spannagel | Head of Quality Assurance - Mechatronics Division Goettingen | S.O. | S.O. | S.O. |
| Ralf Mohrschladt | Physicist & Head of Supply Chain Management - Germany | S.O. | S.O. | S.O. |
| Ms. Petra Muller | Head of Investor Relations | S.O. | S.O. | S.O. |
| Mr. Maurice Phelan | President of Sartorius North America | S.O. | S.O. | S.O. |
| Dr. Theo Thijssen | President of Environmental Technology Division | S.O. | S.O. | S.O. |
Description
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Sartorius Aktiengesellschaft en date du 29 avril 2024 est 8. Les scores principaux sont Audit : 6; Société : 5; Droits des actionnaires : 10; Compensation : 9.
